课题基金 / 基金详情

DECORIN AND BIGLYCAN: STRUCTURE AND FUNCTION

DECORIN AND BIGLYCAN: STRUCTURE AND FUNCTION
核心蛋白聚糖和双聚糖:结构和功能
批准号:
6511846
负责人:
DAVID J. MCQUILLAN
金额:
$23.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-03-31 至 2005-05-31

项目摘要

项目成果

DAVID J. MCQUILLAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract : The small leucine-rich repeat proteoglycans, decorin and biglycan, are biological modulators of extracellular matrix assembly and cell growth in health and diverse pathological conditions such as cancer and fibrotic disease Our central hypothesis is that these closely related members of the small leucine-rich proteoglycan family are multifunctional glycoconjugates that exert their regulatory effects by simultaneously acting on several targets, including: (1) binding to collagen and regulating the temporal and spatial kinetics of fibrillogenesis; (2) modulating the activity and availability of TGF-b, a cytokine that regulates cell proliferation, cell migration, and synthesis of matrix components; and (3) interacting with the epidermal growth factor receptor and thereby modulating cell proliferation. We have shown that the complex folding and post-translational processing of decorin and biglycan are critical to many of their functions. Furthermore, it is clear that the multitude of in vitro activities ascribed to decorin and biglycan may not be physiologically relevant in vivo, and the therapeutic potential of these molecules in fibrotic disease and cancer will only be realized by a systematic approach that demonstrates a direct link between biological activity and physiological response. The goal of this research is to advance understanding of decorin and biglycan biology by elucidating molecular mechanisms by which they regulate extracellular matrix assembly, matrix deposition, and cell growth. We will investigate and characterize in detail the interaction with type I collagen, modulation of TGF-b activity, and influence on EGF-receptor controlled suppression of cell growth. We will map specific binding sites through generation of recombinant proteoglycans, core proteins, decorin-biglycan chimeras, and leucine-rich repeat replacement mutants, wherein the native structure is maintained but specific protein binding domains are disrupted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biglycan as a Therapeutic for Muscular Dystrophy
  • 批准号:
    6798598
  • 项目类别:
  • 资助金额:
    $54.87万
  • 财政年份:
    2002
  • 负责人:
    DAVID J. MCQUILLAN
  • 依托单位:
Biglycan as a Therapeutic for Muscular Dystrophy
  • 批准号:
    6784327
  • 项目类别:
  • 资助金额:
    $55.21万
  • 财政年份:
    2002
  • 负责人:
    DAVID J. MCQUILLAN
  • 依托单位:
Biglycan as a Therapeutic for Muscular Dystrophy
  • 批准号:
    6552202
  • 项目类别:
  • 资助金额:
    $10.03万
  • 财政年份:
    2002
  • 负责人:
    DAVID J. MCQUILLAN
  • 依托单位:
PRECLINICAL TRIAL OF DECORIN IN FIBROTIC DISEASE
  • 批准号:
    6317733
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2000
  • 负责人:
    DAVID J. MCQUILLAN
  • 依托单位:
海外基金